Standardisation of a two-site PTH immunoradiometric assay using various solid phase formats.

Area of Science:

• Biochemistry
• Immunology
• Endocrinology

Background:

• Accurate parathyroid hormone (PTH) level estimation is crucial for managing metabolic bone disorders.
• Existing diagnostic tools may have limitations in sensitivity or specificity.
• Development of novel assays is essential for improved patient care.

Purpose of the Study:

• To develop a simple, sensitive, and specific second-generation immunoradiometric assay (IRMA) for intact PTH.
• To evaluate different solid-phase matrices and antibody immobilization techniques.
• To identify optimal antibody pairs for an intact PTH assay.

Main Methods:

• Antibodies against C-terminal PTH were immobilized on various solid phases (magnetic cellulose, polystyrene tubes) using physical adsorption or covalent coupling.
• N-terminal antibodies were radio-iodinated with [125]I to serve as detector antibodies.
• Assay performance was evaluated using PTH standards and compared with a commercial kit.

Main Results:

• The optimal assay utilized a matched pair of antibodies (70×G67 and 70×G68) immobilized on polystyrene tubes.
• A polyclonal C-terminal PTH antibody was selected as the capture antibody, and an [125]I-labeled polyclonal N-terminal PTH antibody as the tracer.
• Results from the developed assay were comparable to those obtained with a commercial kit.

Conclusions:

• The developed intact PTH IRMA is feasible for routine production.
• This assay offers a potential indigenous alternative for intact PTH measurement.
• Further development can lead to a reliable diagnostic tool for metabolic bone disorders.